This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: John Poirier: Innovator in Oncotherapy
Introduction
John Poirier is a notable inventor recognized for his contributions to the field of oncotherapy. He is currently affiliated with the Memorial Sloan Kettering Cancer Center, where he focuses on innovative cancer treatment solutions. His work is pivotal in advancing therapeutic strategies against cancer.
Latest Patents
John Poirier holds a patent for the "Seneca Valley Virus (SVV) Cellular Receptor Targeted Oncotherapy." This invention represents a significant advancement in targeted cancer therapies, aiming to improve treatment efficacy while minimizing side effects.
Career Highlights
Throughout his career, John has made substantial contributions to cancer research and treatment methodologies. His dedication to improving patient outcomes through innovative therapies has established him as a respected figure in the medical community.
Collaborations
John Poirier has collaborated with esteemed colleagues, including Linde Miles and Charles Rudin. These partnerships have fostered a collaborative environment that enhances research and development in oncotherapy.
Conclusion
John Poirier's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His contributions continue to inspire advancements in oncotherapy and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile